A subset of TCR-T targets viral antigens, a subtype of TCR-T targets tumor-specific mutated proteins (neoantigen), and a subtype of TCR-T targets tumor-associated antigens including cancer/testis (CT) antigens, overexpressed antigens, and differentiation antigens. This evidence concerns the gene TBXT and neoplasm.